Hillevax inc
WebHilleVax, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of novel vaccines. HilleVax operates in the United … WebAbout. Experienced leader in the CRO/Clinical Trials field. Currently the Head of the Sample Management function for a vaccines biopharmaceutical …
Hillevax inc
Did you know?
WebNorovirus is responsible for greater than 90% of epidemic non-bacterial outbreaks of gastroenteritis. [1, 2] 700 M+. Norovirus is estimated to cause approximately 700 million cases of gastroenteritis and 200,000 deaths worldwide annually. [3] $ 60 B+. The global economic burden of norovirus is estimated to be $60.3 billion annually. WebApr 6, 2024 · The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2024. HilleVax, Inc. was founded in 2024 and is headquartered in Boston, Massachusetts.
WebJul 30, 2024 · July 30, 2024, 7:24 AM · 4 min read. A look at the shareholders of HilleVax, Inc. ( NASDAQ:HLVX) can tell us which group is most powerful. Institutions often own shares in more established ... WebShe is currently the Head of Clinical Serology at HilleVax, Inc, a biopharmaceutical company focused on the development and commercialization of a vaccine candidate for Norovirus. Shannon has ...
Web330 feet: How tall the headquarters stands above Uptown Charlotte. 313,000 square feet: Size of the building. 24.1 seconds: How long it takes to reach the top floor from the lobby … WebMar 31, 2024 · HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded ...
WebSep 8, 2024 · Norovirus vaccine . Less than two months after spinning out of Takeda Pharmaceuticals, HilleVax, Inc. secured $135 million in crossover financing to advance the development of its Phase III-ready norovirus vaccine.. The funds will be used to support further clinical development of its virus-like particle (VLP) based vaccine candidate, HIL …
WebFounded by a world-renowned physician-scientist. Tachi Yamada, MD co-founded HilleVax and championed HIL-214 from the time it was acquired by Takeda in 2012. Dr. Yamada … city lights maintenanceWebApr 29, 2024 · As many biopharmas rethink plans to go public on less-than-welcoming U.S. markets, Hillevax Inc. forged ahead, pricing an upsized IPO April 28, offering 11.8 million shares at $17 apiece, the midpoint of its previously proposed range, for gross proceeds of about $200 million. That’s the highest amount raised in a U.S. IPO so far in 2024, which … city lights milwaukeeWebMar 13, 2024 · HilleVax Inc. has set terms for its initial public offering, in which the Massachusetts-based biopharmaceutical company that focuses on developing novel … city lights kklWebOct 1, 2024 · Here’s what you need to know about the new headquarters: 1. The space. The 23-story office building will be built by Charlotte developer Lincoln Harris and construction … city lights miw lyricsWebGet the latest Hillevax Inc (HLVX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. city lights lincolnWebCompany Type For Profit. Contact Email [email protected]. Phone Number (617) 213-5054. HilleVax is a biopharmaceutical company that focuses on the development and … city lights liza minnelliWebHilleVax Inc. annual income statement. View HLVX financial statements in full, including balance sheets and ratios. city lights ministry abilene tx